PD-1/PD-L1 interactions usually occur predominantly in peripheral tissues, however in some cancers, for example lymphoma developing in lymphoid organs, PD-1 engagement can reduce the anti-tumor response of effector T cells. The gene discussed is PDCD1; the disease is neoplasm.